Baker McKenzie advised Abbott Laboratories on the deal. Abbott Laboratories executed the acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately $890 million. ...
This content is for Standard 1 Year members only. LoginJoin Now